CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - 6 months ended Jun. 30, 2015 - USD ($)	Total	Common stock [Member]	Additional paid-in capital [Member]	Retained earnings [Member]	Treasury Stock [Member]	Accumulated other comprehensive income [Member]	Equity attributable To China Biologic Products, Inc. [Member]	Noncontrolling interest [Member]
Balance at Dec. 31, 2014	$ 275,261,730	$ 2,787	$ 24,008,281	$ 244,661,391	$ (76,570,621)	$ 19,985,189	$ 212,087,027	$ 63,174,703
Balance (in shares) at Dec. 31, 2014		27,865,871
Net income	63,897,532			$ 49,886,431			49,886,431	14,011,101
Other comprehensive income	609,243					$ 333,661	333,661	$ 275,582
Share-based compensation	4,033,482		$ 4,033,482				4,033,482
Excess tax benefits from stock option exercises	288,681		210,737				210,737	$ 77,944
Common stock issued in connection with:
Exercise of stock options	$ 771,164	$ 9	771,155				$ 771,164
Exercise of stock options (in shares)		91,209
Vesting of restricted shares		$ 1	(1)
Vesting of restricted shares (in shares)		5,625
Reissuance of treasury stock	$ 80,583,959		60,438,432		$ 20,145,527		$ 80,583,959
Balance at Jun. 30, 2015	$ 425,445,791	$ 2,797	$ 89,462,086	$ 294,547,822	$ (56,425,094)	$ 20,318,850	$ 347,906,461	$ 77,539,330
Balance (in shares) at Jun. 30, 2015		27,962,705